Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $39.3500 (2.18%) ($39.3500 - $39.5200) on Wed. Sep. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.4% (three month average) | RSI | 23 | Latest Price | $39.3500(2.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.7% a day on average for past five trading days. | Weekly Trend | HALO declines -3.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(42%) IWM(35%) IWO(35%) IFRA(34%) IWN(34%) | Factors Impacting HALO price | HALO will decline at least -1.2% in a week (0% probabilities). VIXM(-11%) UUP(-7%) VXX(-6%) TBT(-5%) GLD(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.2% (StdDev 2.4%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.55(-17.28%) | Resistance Level | $41.69 | 5 Day Moving Average | $39.62(-0.68%) | 10 Day Moving Average | $40.37(-2.53%) | 20 Day Moving Average | $41.69(-5.61%) | To recent high | -24.1% | To recent low | 2.2% | Market Cap | $5.378b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |